Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.
Genetics and molecular biology, vol.42, pp.15-25, 2019 (SCI-Expanded)
Article / Article
Genetics and molecular biology
Science Citation Index Expanded (SCI-EXPANDED), Scopus
IRS1, NSCLC, insulin signaling, lung cancer, IRS proteins, GROWTH-FACTOR RECEPTOR, ACTIVATING MUTATIONS, DOWN-REGULATION, PHOSPHORYLATION, EXPRESSION, INSULIN-RECEPTOR-SUBSTRATE-1, PROTEINS, AKT, CHEMOTHERAPY, ASSOCIATION
Van Yüzüncü Yıl University Affiliated: